MDMA or related drug-induced delirium, including MDA

Description

MDMA or related drug-induced delirium, including MDA is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or during the use of MDMA or related drugs. The amount and duration of MDMA or related drug use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders.

Index terms

MDMA or related drug-induced delirium, including MDA
Ecstasy or related drug-induced delirium

Exclusions from above levels

QE11.6 – Hazardous use of MDMA or related drugs
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6C4C.0 – Episode of harmful use of MDMA or related drugs, including MDA
6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA
6C4C.2 – MDMA or related drug dependence, including MDA
6C4C.3 – MDMA or related drug intoxication, including MDA
6C4C.4 – MDMA or related drug withdrawal, including MDA
6C4C.6 – MDMA or related drug-induced psychotic disorder, including MDA
6C4C.7 – Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
6C4C.Y – Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
6C4C.Z – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified

Foundation entity

Allowed postcoordination axes

Part of: 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders